OUR PBIC TEAM
OmniArray is a trademark of Occam Design, LLC
Vas Abramov • President of Occam Design
Vas Abramov Joined CreoSalus in 2005 and became President of Occam Design, a division of CreoSalus, in 2013. Vas has an established record of high performance in multiple venture-backed and private investor-sponsored technology companies. Two of those companies have made the Inc. 500 List. Vas graduated from the University of Louisville with a BS in Mechanical Engineering in 2001. While at the University of Louisville, he started his engineering career at MedVenture, a Louisville-based medical device engineering company focusing on catheter design. Following MedVenture, he started with CreoSalus by leading the development of a new and innovative peptide synthesizer. The Tetras Peptide Synthesizer is still in use in many pharmaceutical research laboratories in the U.S. and around the world. Vas earned his Master’s of Engineering degree from the University of Louisville in 2010. He has over 20 patents issued or pending and has successfully developed more than 30 life science products.
Mike Wilson • Project Engineering Manager
Mike Wilson is the principal designer of the OmniArray™ Porous Brain Infusion Catheter. Mike has 19 years of experience in medical device product development as a project engineer, including leading engineering activities through pre-clinical studies and regulatory approvals. Mike is currently Project Engineering Manager at CreoSalus/Occam Design, leading the development, manufacturing, and testing of the OmniArray™ Porous Brain Infusion Catheter.
Art Crotty • Director of Business Development
Art Crotty is a Medical Device Sales Executive with a successful track record of bringing critical care products to the healthcare market. Art is based in Louisville, KY, and is affiliated with Occam Design, also in Louisville, KY. Art has helped to introduce new technologies and products into hospital-centered critical care and operating room arenas. He has experience in leading products through clinical acceptance and navigating the complexities of the U.S. healthcare purchasing network.
Dmitry Zamoryakhin • Consultant
Dr. Dmitry Zamoryakhin is an accomplished R&D scientist with extensive experience in drug development, oncology, and rare diseases. Most recently, he served as a Chief Scientific Officer and Chief Medical Officer at a UK biotech company, leading R&D across clinical and regulatory domains and advancing therapies for glioblastoma, pediatric brain tumors, and familial adenomatous polyposis through various stages of development. Previously, Dmitry held leadership roles at Oxford Biomedica and Grünenthal, where he drove innovations in gene therapy and drug-device combinations. Dmitry has an MD, an MBA from Warwick Business School, and a diploma in Pharmaceutical Medicine.
Jim Stice • Consultant
Jim Stice is currently a principal with Medcelleration. This Minnesota consulting firm provides medical device IP scouting, project assessment, and management services, including non-dilutive SBIR funding assistance and grant submission preparation. Jim has advised multiple medical device innovators on NIH SBIR Phase I and II strategy and IP scouting, with a focus on medical device execution. Over the past 12 months, Medcelleration clients have obtained a total of $10MM in NIH SBIR/STTR Awards.
Prior to Medcelleration, Jim led Twin Star Medical. This medical device company provided drug-delivery and acute trauma products to researchers and physicians and pioneered the use of a porous device platform across multiple indications. With experience leveraging private equity, Jim has been awarded $20MM in Federal R&D grants over 10 years. He has secured four 510 (k) clearances and two IDE Approvals, and has implemented four IRB-approved pilot clinical studies. Jim has been awarded ten patents for the porous medical device platform. During Jim’s career, he helped launch other medical device and healthcare startups as Founder and/or Board Member in addition to serving as Chairman of Medical Alley. Medical Alley is located in Minneapolis, MN, and is the “world’s foremost network of healthcare organizations”.